| Recruiting | Mechanisms of Response and Resistance to Innovative Treatments in Patients With Locally Advanced or Metastatic Metastatic Breast Cancer | — | 2024-10-15 |
| Completed | Elements of Adaptive Immunity in Epithelial Ovarian Cancer Epithelial High Grade Serous Ovarian Cancer | — | 2023-04-01 |
| Completed | Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan Breast Cancer, Metastatic Cancer | — | 2023-01-01 |
| Unknown | Clinical and Molecular Study With Digital Support of Patients With Inoperable Lung Cancer Non-Small Cell Carcinoma of Lung, TNM Stage 4 | — | 2022-03-23 |
| Recruiting | Real-world Data in Patients With Breast Cancer Treated With Abemaciclib Breast Cancer | — | 2021-10-06 |
| Unknown | Head and Neck cancERs International cOviD-19 collabOraTion Head and Neck Cancer, Covid19 | — | 2021-05-03 |
| Unknown | Durvalumab in Combination With Standard Chemotherapy of Patients With Extensive Stage Small Cell Lung Cancer Small-cell Lung Cancer, Extensive-stage Small-cell Lung Cancer | — | 2021-03-31 |
| Completed | Responses to COVID-19 Vaccination in Patients With Cancer Cancer | — | 2021-01-12 |
| Completed | Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease Autoimmune Diseases, Checkpoint Inhibitor, Immunotherapy | — | 2020-11-01 |
| Unknown | Molecular Profiling in Prostate Cancer Prostate Cancer Metastatic, Prostate Cancer Recurrent, Germline BRCA1 Gene Mutation | — | 2020-10-01 |
| Unknown | Osimertinib as 1st Line Therapy for Patients With Advanced EGFR Positive Non-Small Cell Lung Cancer Lung Cancer Non-small Cell Stage IV | — | 2020-02-01 |
| Unknown | Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer Ovarian Cancer | — | 2019-11-01 |
| Completed | RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line Chemotherapy in Patients With Pancreatic Adenocarcinoma | Phase 1 / Phase 2 | 2019-01-29 |
| Completed | Clinical Outcome and Toxicity Data in Patients With Advanced Breast Cancer Treated With CDK Inhibitors Combine Breast Cancer Stage IV | — | 2019-01-01 |
| Unknown | Immunotherapy in Combination With Chemotherapy in Small-cell Lung Cancer Small Cell Lung Carcinoma | Phase 2 | 2018-09-16 |
| Terminated | Anti-EGFR Therapy Rechallenge in Combination With Chemotherapy in Patients With Advanced Colorectal Cancer Advanced Colorectal Cancer | Phase 2 | 2018-03-26 |
| Unknown | Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer Ovarian Cancer | — | 2018-02-09 |
| Completed | Tumor Molecular Profiling in Patients With Prostate Cancer Prostate Cancer, Metastatic Prostate Adenocarcinoma | — | 2018-01-01 |
| Completed | Preoperative Administration of Olaparib With Cisplatin or With Durvalumab or Alone or no Tratment in Patients Squamous Cell Carcinoma of the Head and Neck | Phase 2 | 2016-10-20 |
| Completed | Germline Mutations in Pancreatic Adenocarcinoma Germline Mutation Abnormality, Pancreatic Cancer, Predisposition, Genetic | — | 2016-03-01 |
| Completed | Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer Bone Metastatic Prostate Cancer | Phase 2 | 2015-10-29 |
| Completed | Real-world Data of Nivolumab in Pre-treated NSCLC Non Small Cell Lung Cancer | — | 2015-10-01 |
| Completed | The Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients With Advanced EGFR Non Small Cell Lung Cancer, EGF-R Positive Non-Small Cell Lung Cancer, EGFR Gene Mutation | — | 2015-03-15 |
| Completed | Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer Gastric Cancer Stage IV, Second-line Treatment, Ramucirumab Paclitaxel | — | 2015-03-01 |
| Completed | Molecular Characterization of Gliomas Using a Broad Next Generation Sequencing (NGS)Panel Malignant Glioma | — | 2015-02-04 |
| Completed | HNSCC Immuno-genomics Project Molecular Classification of HNSCC | — | 2014-12-19 |
| Completed | Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal Cancer Metastatic Colorectal Cancer | Phase 2 | 2014-05-26 |
| Active Not Recruiting | Gene Molecular Alterations as Disease Prognostic Markers in Patients With Non-small Cell Lung Cancer (NSCLC) NSCLC (Non-small Cell Lung Cancer) | — | 2013-09-09 |
| Terminated | Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tr Cholangiocarcinoma, Gallbladder Carcinoma, Biliary Carcinoma | Phase 2 | 2013-06-28 |
| Unknown | Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes Breast Cancer | — | 2013-04-24 |
| Unknown | Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenoca Breast Cancer | — | 2013-04-18 |
| Completed | Clinical Trial of Chemotherapy Combination Cisplatin-Fluorouracil-Afatinib in Patients With Inoperable Gastric Gastric Cancer, Gastroesophageal Junction Cancer | Phase 2 | 2013-02-11 |
| Completed | Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes Breast Cancer | Phase 2 | 2012-09-01 |
| Terminated | Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors Gastrointestinal Tumors, Pancreatic Tumors, Gastrointestinal Neuroendocrine Tumors | Phase 2 | 2012-08-06 |
| Terminated | Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma Kidney Cancer | Phase 2 | 2010-12-01 |
| Completed | Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors Brain Metastases, Lung Tumors, Breast Tumors | Phase 2 | 2010-10-01 |
| Completed | Study of Panitumumab-Capecitabine-Oxaliplatin In Wild-Type K-Ras Metastatic Colorectal Cancer Patients Colorectal Cancer | Phase 2 | 2010-09-01 |
| Terminated | Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse Ovarian Cancer | Phase 2 | 2009-06-01 |
| Terminated | Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT) Metastatic Breast Cancer | Phase 2 | 2008-11-01 |
| Completed | Bevacizumab Versus Docetaxel/Erlotinib on Tumor Metrics in Patients With Previously Untreated Advanced Non Sma Non Small Cell Lung Cancer | — | 2008-11-01 |
| Terminated | Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC) Advanced Non-Small Cell Lung Cancer | Phase 2 | 2008-11-01 |
| Unknown | Molecular Profiling of Colorectal Cancer Colorectal Cancer, Colon Cancer, Colon Adenocarcinoma | — | 2006-01-01 |
| Completed | Metronomic Oral Vinorelbine in Patients With Metastatic Tumors Breast Cancer, Non Small Cell Lung Cancer, Prostate Cancer | Phase 2 | 2006-01-01 |
| Completed | Adjuvant Chemotherapy With Epirubicin, CMF, and Weekly Docetaxel or Weekly Paclitaxel in Patients With Resecte Breast Cancer, Adenocarcinoma of Breast | — | 2004-02-01 |
| Completed | Pathogenic Variants in Homologous Recombination Repair Genes in Patients With Epithelial Ovarian Cancer Epithelial Ovarian Cancer | — | 2004-01-01 |
| Completed | Prognostic Biomarkers in Patients With Urothelial Carcinoma Bladder Cancer | — | 2000-05-01 |
| Completed | K-RAS and EGFR in Lung Cancer Non Small Cell Lung Cancer | — | 2000-03-01 |
| Unknown | Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer Metastatic Breast Cancer | — | 1998-07-05 |
| Unknown | Melanoma: Genomic Profiles, Molecular Markers and Therapeutic Implications Melanoma | — | 1998-02-01 |
| Completed | Corellation of Mutations, TILs and Age in Breast Cancer Breast Cancer | — | 1997-09-03 |
| Completed | Pooled Analysis of Patients With Early-stage Breast Cancer Treated With Adjuvant Dose-dense Sequential Chemoth Breast Cancer, Early Stage Breast Cancer, Adjuvant Chemotherapy | — | 1996-12-15 |